As of 2026-04-01, 白云山（广药集团）'s data on the DeepSeek platform in the 制药企业 category shows: The overall mention rate is 0.00%, below the industry average by 10.2 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 白云山（广药集团）'s overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
白云山（广药集团）'s Mention Rate is 0.00%, lower than 0.6% of competitors
白云山（广药集团）'s First Mention is 0.00%, lower than 0.9% of competitors
白云山（广药集团）'s Preferred Rate is 0.00%, lower than 100.0% of competitors
白云山（广药集团）'s Positive Rate is 0.00%, lower than 8.9% of competitors
白云山（广药集团）'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 罗罗氏 | 47.37% | 7.89% | 18.18% | 39.47% | 5.26% | View Details |
| 辉辉瑞 | 34.21% | 5.26% | 18.18% | 28.95% | 13.16% | View Details |
| 强强生 | 31.58% | 7.89% | 0% | 28.95% | 10.53% | View Details |
| 诺诺华 | 31.58% | 0% | 0% | 21.05% | 5.26% | View Details |
| 同同仁堂 | 28.95% | 2.63% | 0% | 15.79% | 18.42% | View Details |
| 云云南白药 | 18.42% | 0% | 0% | 18.42% | 0% | View Details |
| 白白云山（广药集团） (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
